# Remohab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/remohab

- Industry: Healthcare IT
- Headquarters: Suita, Japan
- Website: www.remohab.com
- Total disclosed funding: $3.7M
- Latest round: Series B (Apr 1, 2020)
- Investors on record: 7

## About

Remohab Inc. is dedicated to developing innovative remote medical solutions that address critical health issues, including heart disease and home rehabilitation, through advanced telemedicine platforms for effective patient care.Founded in 2017 in Suita, Japan, Remohab Inc. specializes in remote medical solutions, primarily focusing on telemedicine for heart disease management and home rehabilitation. The company has undergone strategic adjustments but has not pivoted from its core mission. CEO Tatsunori Taniguchi, who has a background in healthcare innovation, leads the company. In March 2022, Remohab completed a Series B funding round, raising JPY 80.000 mn, with the Industrial Technology Investment Corporation and SMBC Venture Capital as investors, bringing the total amount raised to JPY 80.000 mn and the current company valuation to JPY 1,351.576 mn.???????? (Remohab) specializes in designing and delivering innovative remote medical solutions aimed at addressing significant health challenges, specifically in the areas of heart disease, heart failure, home rehabilitation, and remote consultations. Their primary offerings encompass advanced telemedicine platforms that facilitate real-time patient monitoring and virtual care, enabling healthcare professionals to conduct remote consultations and manage patient treatment plans effectively. These services are particularly valuable for patients requiring ongoing care and support, allowing them to receive medical attention without the need for frequent hospital visits. The company's solutions cater to healthcare providers, clinics, and hospitals, targeting markets in Japan and potentially expanding to other regions where telehealth services are in high demand. By leveraging technology, Remohab enhances patient accessibility to healthcare while improving overall outcomes and efficiency in the management of chronic conditions.The revenue model for ???????? is structured around service subscriptions and partnerships with healthcare institutions. This involves creating tailored agreements with hospitals and clinics that integrate Remohab's telemedicine solutions into their existing systems. Healthcare providers may subscribe to a monthly service plan that includes access to the company's remote monitoring tools and consultation capabilities, allowing them to provide enhanced care to their patients. Transactions typically occur through direct client engagement, where healthcare organizations assess their needs and negotiate service terms directly with Remohab's sales team. The pricing plans for these services reflect the comprehensive nature of the solutions offered, aimed at ensuring that both large healthcare networks and smaller practices can benefit from the accessibility and efficiency provided by Remohab's technology.Looking ahead, Remohab Inc. aims to expand its product offerings, with new telehealth solutions currently in development set to launch in the next year. The company plans to penetrate additional markets in Asia and potentially other regions by the end of 2024, leveraging its recent Series B funding of JPY 80.000 mn to enhance its technology and market reach. Additionally, in March 2022, AIR WATER INC. acquired a 63.2% stake in Remohab, which is expected to facilitate further growth and investment into new healthcare technologies.

## Funding rounds

- Series B, Apr 1, 2020, $0.7M — Industrial Technology Investment Corporation, SMBC Venture Capital
- Series B, Jan 20, 2020, $2.5M — Mitsubishi UFJ Capital, Senshu Ikeda Capital, Osaka University Venture Capital, Shinkin Capital, Hack Ventures
- Series A, Jul 26, 2018, $0.5M — Osaka University Venture Capital, Hack Ventures

## Investors

- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A, Series B
- Hack Ventures (https://capitalatlas.ai/funds/hack-ventures) — Series A, Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series B
- Senshu Ikeda Capital (https://capitalatlas.ai/funds/senshu-ikeda-capital) — Series B
- Shinkin Capital (https://capitalatlas.ai/funds/shinkin-capital) — Series B
- Industrial Technology Investment Corporation (https://capitalatlas.ai/funds/industrial-technology-investment-corporation) — Series B
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B